In general, how can investigators address potential effects of COVID-19 on patients in a cardiovascular outcomes trial
Research in neurodegenerative diseases like Alzheimers suggests these medications may reduce neuroinflammation and protect against beta-amyloid plaque formation
Foundayo (Orforglipron) A recent addition to the weight loss realm, Foundayo is a versatile GLP-1 oral medication approved in April 2026
Bloodwork, blood pressure, and body composition shifts all factor in
But like any medicine, HRT isnt risk-free
Surveys, blood tests, movement sensors, and brain imaging revealed how the diet changed their mood, energy levels, and metabolic markers